Additionally, amplification of both HSD17B1 and HSD17B2 gene isoforms did not affect the survival of breast cancer, where p-values were 0.861 and 0.618, respectively (Figure 4E’,F’). This evidence concerns the gene HSD17B1 and breast carcinoma.